Immunome Inc.

NASDAQ: IMNM · Real-Time Price · USD
10.26
0.32 (3.22%)
At close: Aug 15, 2025, 3:59 PM
10.40
1.41%
After-hours: Aug 15, 2025, 06:45 PM EDT

Immunome Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
4.01M 2.93M 2.74M 2.91M 2.36M 1.03M 3.83M 3.56M 4.26M 2.36M n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
720K 726K 595K 571K 673K 263K 257K 166K 157K 148K 260K 114K 121K 136K 118K 286K 175K 176K
Gross Profit
4.01M 2.93M 2.74M 2.91M 2.36M 1.03M 3.83M 3.4M 4.11M 2.22M -260K -114K -121K -136K -118K -286K -175K -176K
Operating Income
-46.48M -44.64M -82.97M -50.52M -40.01M -132.3M -94.65M -4.63M -5.77M -4.47M -7.79M -8.53M -8.93M -11.65M -7.84M -7.72M -5.74M -3.9M
Interest Income
3.08M 3M 2.72M 3.42M 3.89M 2.81M 2.02M 288K 216K 201K 1K 1K 2K 1K n/a n/a n/a n/a
Pretax Income
-43.4M -41.64M -80.25M -47.1M -36.12M -129.49M -92.63M -4.34M -5.56M -4.27M -7.79M -8.53M -8.92M -11.65M -7.85M -7.72M -5.24M -3.9M
Net Income
-43.4M -41.64M -80.25M -47.1M -36.12M -129.49M -92.63M -4.34M -5.56M -4.07M -8.4M -8.53M -8.92M -11.65M -7.85M -7.72M -5.24M -3.9M
Selling & General & Admin
10.04M 10.69M 10.45M 9.53M 6.98M 6M 8.04M 4.38M 4.32M 2.92M 3.54M 3.31M 3.21M 3.58M 3.46M 3.21M 2.51M 1.92M
Research & Development
40.45M 36.87M 47.89M 37.2M 29.08M 15.37M 9.64M 3.82M 5.72M 3.91M 4.25M 5.22M 5.72M 8.08M 4.38M 4.51M 3.23M 1.98M
Other Expenses
n/a n/a 27.37M 6.71M 6.31M 111.95M 80.8M -166K n/a n/a n/a n/a n/a n/a -3K 6K 500K n/a
Operating Expenses
50.49M 47.56M 85.71M 53.43M 42.37M 133.33M 98.48M 8.03M 10.04M 6.83M 7.79M 8.53M 8.93M 11.65M 7.84M 7.72M 5.74M 3.9M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 4K n/a n/a n/a 5K 3K 1K 1K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
50.49M 47.56M 85.71M 53.43M 42.37M 133.33M 98.48M 8.2M 10.04M 6.83M 7.79M 8.53M 8.93M 11.65M 7.84M 7.72M 5.74M 3.9M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a 34.91K -201K 618K -1K -2K -1K 6K 9K 1K n/a
Shares Outstanding (Basic)
87.01M 79.41M 62.7M 60.21M 59.94M 10.31M 21.95M 12.2M 12.2M 12.18M 12.13M 12.13M 12.06M 12.12M 11.93M 11.88M 11.39M 10.64M
Shares Outstanding (Diluted)
87.01M 79.41M 62.7M 60.21M 59.94M 10.31M 21.95M 12.2M 12.2M 12.18M 12.13M 12.13M 12.13M 12.12M 11.93M 11.93M 11.46M 10.64M
EPS (Basic)
-0.5 -0.52 -1.28 -0.78 -0.6 -12.56 -4.22 -0.36 -0.46 -0.33 -0.69 -0.7 -0.74 -0.96 -0.66 -0.65 -0.46 -0.37
EPS (Diluted)
-0.5 -0.52 -1.28 -0.78 -0.6 -12.56 -4.22 -0.36 -0.46 -0.33 -0.69 -0.7 -0.74 -0.96 -0.66 -0.65 -0.46 -0.37
EBITDA
-45.76M -43.91M -55M -43.24M -33.02M -20.08M -13.59M -4.47M -5.62M -4.32M -7.53M -8.42M -8.8M -11.52M -7.73M -7.44M -5.57M -3.72M
EBIT
-46.48M -44.64M -55.6M -43.82M -33.7M -20.34M -13.85M -4.63M -5.77M -4.47M -7.79M -8.53M -8.93M -11.65M -7.85M -7.72M -5.74M -3.9M
Depreciation & Amortization
720K 726K 595K 571K 673K 263K 257K 166K 157K 148K 260K 114K 121K 136K 118K 286K 175K 176K